


Ask a doctor about a prescription for ARIPIPRAZOLE AUROVITAS 1 mg/ml ORAL SOLUTION
Package Leaflet: Information for the User
Aripiprazole Aurovitas 1 mg/ml Oral Solution EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Aripiprazole Aurovitas oral solution contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat adults and adolescents aged 15 and older who suffer from a disease characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and emotional and behavioral monotony. People in this state may also feel depressed, guilty, restless, or tense.
Aripiprazole is used to treat adults and adolescents aged 13 and older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing to sleep much less than usual, talking very quickly with flight of ideas, and sometimes severe irritability. In adults, it also prevents this situation in patients who have responded to treatment with aripiprazole.
Do not take Aripiprazole Aurovitas
Warnings and precautions
Talk to your doctor before starting to take aripiprazole.
There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole. Tell your doctor immediately if you have thoughts or feelings of harming yourself.
Before starting treatment with aripiprazole, tell your doctor if you suffer from:
blood clots or a family history of blood clots, as antipsychotics have been associated with the formation of blood clots.
If you notice that you are gaining weight, developing unusual movements, experiencing drowsiness that interferes with your normal daily activities, having difficulty swallowing, or presenting allergic symptoms, please inform your doctor.
If you suffer from dementia (loss of memory and other mental abilities), you or the person caring for you or a family member should inform your doctor if you have ever had a stroke or "mini" stroke.
Talk to your doctor immediately if you have thoughts or feelings of harming yourself. There have been reports of patients experiencing suicidal thoughts and behaviors during treatment with aripiprazole.
Talk to your doctor immediately if you experience numbness or stiffness of the muscles with high fever, sweating, altered mental state, or a very fast or irregular heartbeat.
Tell your doctor if you, your family/caregiver notice that you are developing impulses or urges to behave in an unusual way and that you cannot resist the impulse, instinct, or temptation to carry out certain activities that may harm you or others. This is called impulse control disorder and may include behaviors such as addiction to gambling, excessive eating or spending, abnormally high sexual appetite, or concern about an increase in sexual thoughts and feelings.
Your doctor may consider adjusting or interrupting the dose.
Children and adolescents
Do not use this medicine in children and adolescents under 13 years of age. It is not known if it is safe and effective in these patients.
Other medicines and Aripiprazole Aurovitas
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those without a prescription.
Medicines that lower blood pressure: aripiprazole may increase the effect of medicines used to lower blood pressure. Make sure to tell your doctor if you use any medicine to control blood pressure.
If you are taking aripiprazole with another medicine, it may mean that your doctor needs to change your dose of aripiprazole or the other medicine. It is especially important that you mention to your doctor if you are taking:
certain medicines to treat HIV infection (such as efavirenz, nevirapine, and protease inhibitors such as indinavir, ritonavir).
certain antibiotics used to treat tuberculosis (rifabutin, rifampicin).
Medicines that increase serotonin levels are commonly used in diseases that include depression, generalized anxiety disorder, obsessive-compulsive disorder (OCD), and social phobia, as well as migraine and pain:
other antidepressants (such as venlafaxine and tryptophan), used in severe depression.
These medicines may increase the risk of side effects; if you notice any unusual symptoms when taking any of these medicines at the same time as aripiprazole, you should tell your doctor.
Taking Aripiprazole Aurovitas with food, drinks, and alcohol
This medicine can be taken with or without food. However, the oral solution should not be diluted with other liquids or mixed with food before administration.
Alcohol consumption should be avoided.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
The following symptoms may occur in newborn babies of mothers who have been treated with aripiprazole in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
If you are taking aripiprazole, your doctor will discuss with you whether you should breastfeed, considering the benefit of treatment for you and the benefit of breastfeeding for your baby. You should not do both. Talk to your doctor about the best way to feed your baby if you are taking this medicine.
Driving and using machines
During treatment with this medicine, dizziness and vision problems (see section 4) may occur. This should be taken into account when maximum attention is required, e.g., when driving or operating machinery.
Aripiprazole Aurovitas contains fructose
Each ml of aripiprazole contains 200 mg of fructose. If your doctor has told you that you have an intolerance to certain sugars, or if you have been diagnosed with hereditary fructose intolerance (HFI), a rare genetic disorder in which a person cannot break down fructose, consult with them before taking this medicine.
Fructose and sucrose can harm teeth.
Aripiprazole oral solution contains sucrose
Each ml of Aripiprazole oral solution contains 400 mg of sucrose. In patients with diabetes mellitus, the administration of 12.5 ml or more of Aripiprazole oral solution per dose (containing at least 5 g of sucrose) should be taken into account. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine. It may be harmful to teeth.
Aripiprazole Aurovitas oral solution contains parahydroxybenzoates
The oral solution contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.
They may cause allergic reactions (possibly delayed).
Aripiprazole Aurovitas contains propylene glycol
This medicine contains 53 mg of propylene glycol in each ml of oral solution.
Aripiprazole Aurovitas contains benzyl alcohol
This medicine contains 0.3 mg of benzyl alcohol in each ml of oral solution. Benzyl alcohol may cause allergic reactions. Consult your doctor or pharmacist if you have liver or kidney disease. Consult your doctor or pharmacist if you are pregnant or breastfeeding, as large amounts of benzyl alcohol can accumulate in your body and cause side effects (metabolic acidosis).
Aripiprazole Aurovitas contains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per unit dose; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.
The recommended dose for adults is 15 ml of solution (corresponding to 15 mg of aripiprazole) once a day.However, your doctor may prescribe lower or higher doses up to a maximum of 30 ml (i.e., 30 mg) once a day.
Use in children and adolescents
The recommended dose for adolescents is 10 ml of solution (corresponding to 10 mg of aripiprazole) once a day.However, your doctor may prescribe lower or higher doses up to a maximum of 30 ml (i.e., 30 mg) once a day.
This dose of aripiprazole should be measured using the calibrated stopper or the 2 ml calibrated dropper that comes in the packaging.
If you think that the effect of aripiprazole is too strong or too weak, tell your doctor or pharmacist.
Try to take Aripiprazole Aurovitas at the same time every day.It does not matter if you take it with or without food. However, it should not be diluted with other liquids or mixed with food before taking aripiprazole.
Even if you feel better, do not change or interrupt the daily dose of aripiprazole without consulting your doctor first.
If you take more Aripiprazole Aurovitas than you should
If you realize that you have taken more aripiprazole than your doctor recommended (or if someone else has taken part of your aripiprazole), contact your doctor immediately. If you cannot contact your doctor, go to the nearest hospital and take the packaging with you.
Patient who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
stiffness and drowsiness, slower breathing, choking, high or low blood pressure, abnormal heart rhythms.
Contact your doctor or the nearest hospital immediately if you experience any of the above symptoms.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken. It is recommended to take the packaging and the leaflet of the medicine to the healthcare professional.
If you forget to take Aripiprazole Aurovitas
If you forget a dose, take the forgotten dose as soon as you remember, but do not take a double dose to make up for the forgotten dose.
If you stop taking Aripiprazole Aurovitas
Do not stop your treatment just because you feel better. It is important that you continue taking aripiprazole for the time that your doctor has indicated.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Frequent adverse effects (may affect up to 1 in 10 people):
Uncommon adverse effects (may affect up to 1 in 100 people):
The following adverse effects have been reported during the post-marketing phase of
oral aripiprazole, but the frequency of occurrence is unknown:
swelling, pain, and redness of the leg), which can travel through the bloodstream to the lungs, causing chest pain and difficulty breathing (if you notice any of these symptoms, seek medical attention immediately),
compulsive eating (consuming more food than normal and more than necessary to satisfy hunger),
Inform your doctor if you experience any of these behaviors; he/she will explain how to manage or reduce the symptoms.
In elderly patients with dementia, a higher number of fatal cases have been reported while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other Adverse Effects in Children and Adolescents
Adolescents 13 years or older experienced adverse effects similar in frequency and type to those of adults, except for drowsiness, spasms, or uncontrollable contractions, restlessness, and fatigue, which were very frequent (affecting more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when standing up after sitting or lying down, which were frequent (affecting more than 1 in 100 patients).
Reporting Adverse Effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date stated on the carton after CAD. The expiration date is the last day of the month indicated.
This medicine does not require special storage conditions.
Once the package is opened, use within 6 months.
Medicines should not be disposed of via wastewater or household waste. Deposit the packages and medicines you no longer need at the SIGRE collection point in your pharmacy. Ask your pharmacist how to dispose of packages and medicines you no longer need. This will help protect the environment.
Composition of Aripiprazol Aurovitas
propylene glycol, benzyl alcohol, concentrated hydrochloric acid, sodium hydroxide, purified water.
Appearance of the Product and Package Contents
Aripiprazol Aurovitas 1 mg/ml oral solution EFG is a clear, colorless to light yellow liquid available in child-resistant polypropylene bottles containing 50, 150, or 480 ml per bottle.
Each carton contains 1 bottle, a calibrated polypropylene measuring cap, and a calibrated polypropylene dropper.
The dropper is graduated for dosing of 0.5 ml and 1 ml, and then each 0.5 ml up to 2 ml. The measuring cap is graduated for dosing of 5 ml, 10 ml, 15 ml, 20 ml, 25 ml, and a maximum volume of 30 ml.
Only some package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
Aurovitas Spain, S.A.U.
Avda. de Burgos, 16-D
28036 Madrid
Spain
Manufacturer:
APL Swift Services (Malta) Limited
HF26, Hal Far Industrial Estate, Hal Far
Birzebbugia, BBG 3000
Malta
Or
Generis Farmacêutica, S.A.
Rua João de Deus, 19
2700-487 Amadora
Portugal
Or
Arrow Génériques
26 avenue Tony Garnier
69007 Lyon
France
This medicine is authorized in the Member States of the European Economic Area under the following names:
France: Aripiprazole Arrow 1 mg/ml solution buvable
Germany: Aripiprazol PUREN 1 mg/ml Lösung zum Einnehmen
Italy: Aripiprazolo Aurobindo Italia
Portugal: Aripiprazol Aurovitas
Spain: Aripiprazol Aurovitas 1 mg/ml oral solution EFG
Netherlands: Aripiprazol Aurobindo 1 mg/ml, drank
Date of the Last Revision of this Leaflet:January 2023
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es)
The average price of ARIPIPRAZOLE AUROVITAS 1 mg/ml ORAL SOLUTION in November, 2025 is around 25.27 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for ARIPIPRAZOLE AUROVITAS 1 mg/ml ORAL SOLUTION – subject to medical assessment and local rules.